Crewe Advisors LLC Bio N Tech Se Put Options Transaction History
Crewe Advisors LLC
- $695 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40.7MCall Options Held
1.39MPut Options Held
1.5M-
Baillie Gifford & CO8.16MShares$753 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$393 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$374 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$175 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$167 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $22.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...